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Abstract
Nutrients such as amino acids play key roles in shaping the metabolism of microorganisms in
natural environments and in host–pathogen interactions. Beyond taking part to cellular metabo-
lism and to protein synthesis, amino acids are also signaling molecules able to influence group
behavior in microorganisms, such as biofilm formation. This lifestyle switch involves complex
metabolic reprogramming controlled by local variation of the second messenger 30 , 50-cyclic
diguanylic acid (c-di-GMP). The intracellular levels of this dinucleotide are finely tuned by the
opposite activity of dedicated diguanylate cyclases (GGDEF signature) and phosphodiesterases
(EAL and HD-GYP signatures), which are usually allosterically controlled by a plethora of envi-
ronmental and metabolic clues. Among the genes putatively involved in controlling c-di-GMP
levels in P. aeruginosa, we found that the multidomain transmembrane protein PA0575, bearing
the tandem signature GGDEF-EAL, is an L-arginine sensor able to hydrolyse c-di-GMP. Here, we
investigate the basis of arginine recognition by integrating bioinformatics, molecular biophysics
and microbiology. Although the role of nutrients such as L-arginine in controlling the cellular fate
in P. aeruginosa (including biofilm, pathogenicity and virulence) is already well established, we
identified the first L-arginine sensor able to link environment sensing, c-di-GMP signaling and
biofilm formation in this bacterium.
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1 | INTRODUCTION
The 30 ,50-cyclic diguanylic acid (c-di-GMP) is an ubiquitous dinucleo-
tide in bacteria, controlling complex processes such as the transition
from single-cell motile state to biofilm and cellular differentiation.1
The intracellular levels of c-di-GMP are modulated by the opposite
activities of diguanylate cyclases (DGCs), containing GGDEF domains,
and phosphodiesterases (PDEs), containing either EAL or HD-GYP
domains, responsible for the synthesis and degradation of c-di-GMP,
respectively.1 In general, high levels of c-di-GMP are associated to
biofilm formation, while a decrease in its intracellular levels pairs with
biofilm dispersal.1 However, it has been demonstrated that the com-
plex and redundant network of DGCs/PDEs enzymes impacts on sev-
eral other processes that are not necessarily related to biofilm, by
finely regulating c-di-GMP levels.2–4 To further complicate the sce-
nario, genetic mutants in putative DGCs and/or PDEs showed unex-
pected phenotypes in terms of biofilm formation/dispersal.5,6
A recent analysis on the regulation of the c-di-GMP network in
Pseudomonas fluorescens Pf01 clearly showed that multifaceted regu-
latory strategies can take place to achieve the final phenotype, includ-
ing combinations of ligand-mediated signals and/or transcriptional
regulation.5 Therefore, it appears that multiple signaling pathways
could act together to obtain a unique c-di-GMP-dependent pheno-
type, and that different pathways could lead to the same output. In
this regard, the activity of DGCs and PDEs is often allosterically regu-
lated by environmental/metabolic signals acting on upstream sensory
domains.1 Indeed, several environmental and metabolic signals charac-
terized so far dramatically change the overall structure of the target
protein, affecting cooperativity in catalysis, protein oligomerization or
protein-protein interaction.7–9 However, regardless of the molecularA. Paiardini and F. Mantoni contributed equally to the work.
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mechanisms, the common trait of c-di-GMP network is that nutrients
are among the most important driving signals leading to c-di-GMP-
mediated metabolic reprogramming. In particular, it has been shown
that sensing of metabolites relevant to central metabolism, such as
amino acids, links the reshaping of such metabolism with the modifica-
tions of c-di-GMP-levels.10–12 To date, few data are available on such
strategies of nutrients sensing, although the re-profiling of central
metabolism represents a novel perspective to tackle the biofilm
issue.11,13
Among periplasmic domains known to be involved in nutrients
sensing, the Venus flytrap (VFT) of the periplasmic binding proteins
(PBPs) is the most representative.14 Nutrients recognized by PBPs
include mono- and oligosaccharides, amino acids, oligopeptides, oxya-
nions, cations, and vitamins. In general, PBPs trap nutrients for their
internalization into bacteria by ABC transporters; they are commonly
in the same operon of the permease counterpart.15 Nevertheless, the
PBP-fold and specificity is conserved also when fused to diverse sen-
sory/transduction systems, not necessarily linked to the import event
(ie, the so-called “sensor-PBPs”), conserved both in prokaryotes and in
eukaryotes.14,16–18
Regardless of the function, ligand binding triggers closure of the
VFT by bringing its two domains together, like a Venus flytrap of the
carnivorous plant Dionaea muscipula, from which its name derives.
This closure allows the PBP-ligand complex to be competent for the
interaction with the permease or, if fused to a membrane protein, to
initiate the intracellular signal transduction downstream the
polypeptide.
To deepen the knowledge on the control of c-di-GMP levels in
response to nutrients related to central metabolism, in this work we
focused our analysis on PA0575, a so far poorly characterized protein
from P. aeruginosa. PA0575 is a multidomain hybrid protein containing
a VFT domain, four Per-Arnt-Sim (PAS) domains and a GGDEF-EAL
effector superdomain. Initial biological studies on the PA0575 horto-
logue gene in P. aeruginosa PA14 (named PA14_07500, 99% sequence
identity) could not assign an enzymatic activity,19 while in a following
study a PA14 strain carrying PA14_07500 deletion showed severely
reduced swarming and swimming motility.20 More recently, the same
PA14_07500 gene has been shown to display slightly different sur-
face behaviors, while controlling matrix production and colony mor-
phogenesis in response to the cellular redox state and pyocyanin, and
accordingly named RmcA (Redox regulator of c-di-GMP).21 It is likely
that redox-sensing is mediated by one of the PAS domains in the
cytoplasmic side of the protein, given that these domains function as
input modules in proteins that sense oxygen, redox potential, light,
and some other stimuli.22 The diversity of phenotypes reported
strongly suggest that the function of this protein is deeply affected by
the environmental signals, and suggests that rather small variations in
cultural conditions may result in different phenotypes.
Using a multidisciplinary approach, including bioinformatics, pro-
tein engineering and microbiology, we describe here a novel mecha-
nism of L-arginine sensing related to the VFT domain of PA0575, and
relevant to c-di-GMP metabolism. L-arginine plays a key role in
P. aeruginosa pathogenesis and antibiotic resistance.23–25 Noteworthy,
in P. aeruginosa L-Arginine is at the crossroads of multiple anabolic and
catabolic/energy pathways,11 particularly under anaerobic conditions,
thus widening the metabolic versatility of this bacterium. L-arginine
metabolism is emerging as a crucial factor in complex biological pro-
cesses involving metabolic-reprogramming, such as those related to
bacterial biofilm formation and virulence, immune response and can-
cer.26,27 Interestingly, recent data suggest that L-arginine is perceived
and catabolized by bacteria during infection to escape the host
defense strategies by (i) changing the pH (due to the ammonium pro-
duction) and (ii) contrasting the iNOS-mediated nitric oxide produc-
tion, (by depleting the host of the iNOS substrate, ie, L-Arginine).27
Therefore, the identification of a novel L-Arginine sensor in
P. aeruginosa, as presented in this article, represents a contribution to
the characterization of the mechanisms controlling host-pathogen
interaction.
2 | MATERIALS AND METHODS
For experiments reported in the Supporting Information materials, the
procedures are reported in the corresponding figure legends.
2.1 | PA0575 domains modeling
The program Phyre228 was used to detect template folds for the N-
terminal periplasmic domain (PP domain; 20-274) and the best hits
(Accuracy = 100%) found were chosen for model construction, and
aligned to detect structurally conserved regions (SCRs) using PyMod
2.0.29,30 A multiple sequence alignment between PA0575 and tem-
plates was obtained using the program Muscle.31 The alignment was
then used for the secondary structure prediction (PhD server)32 and
for detection of evolutionary conserved residues.33 An initial align-
ment between the structural templates and the PA0575 sequence
constructed based solely on sequence similarity. The alignment was
then manually optimized to match several characteristics, including
the observed and predicted secondary elements, the hydrophobic
regions in the three-dimensional structures, the structurally and func-
tionally conserved residues and the SCRs. Care was taken to insert
gaps preferably in regions which correspond to loops in the crystal
structures. Pymod 2.0 was used for the manipulation of alignments
and to merge the predicted models in a multidomain model. Protein
monomeric models were constructed using the Modeler package.34
One hundred different models were built and evaluated using several
criteria: the model displaying the lowest objective function was taken
as the representative one, and analyzed with Dope Score and Veri-
fy_3d35 to monitor its stereochemical quality.
2.2 | Protein expression and purification
PA0575 gene was amplified by PCR from genomic PAO1 DNA and
subcloned (NdeI/BamHI) as N-terminal His-tag construct in Pet28b.
From this template, the construct encompassing residues 21-255
(hereinafter VFT) was subcloned by PCR (NdeI/XhoI) into the same
vector.
Site-directed mutants were obtained using the Quikchange Light-
ning kit (Agilent Technologies, Santa Clara, CA) according to the
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manufacturer's instructions; PCR and mutagenesis were confirmed by
DNA sequencing.
VFT and full-length were overexpressed in the E. coli BL21 (DE3)
strain. Bacterial cultures were grown at 37C in Luria-Bertani
(LB) liquid medium supplemented with 30 μg mL−1 Kanamycin
(Sigma). When OD600  0.8, the temperature was reduced to 20C
and protein expression was induced by adding 0.5 mM IPTG (isopro-
pyl β-D-thiogalactoside; Sigma). Cells were harvested by centrifugation
after 20 h and stored at −20C. Bacterial pellets were suspended in
lysis buffer containing 250 mM NaCl, 50 mM Tris-HCl pH 8, 1 mM
PMSF and 1 complete protease inhibitor (Roche) (+2% v/v Tween20
in the full-length sample) and lysed by sonication on ice. After centri-
fugation, the proteins were purified by affinity chromatography using
a HisTrap column (GE Healthcare) loaded with Ni2+ and equilibrated
with Buffer A (20 mM Tris-HCl pH 8.5, 150 mM NaCl, for VFT;
20 mM Tris-HCl pH 7.5, 250 mM NaCl, +2% v/v Tween20, for full-
length). Elution was carried out increasing the imidazole concentra-
tion, with the full-length protein eluting at 300 mM imidazole and
VFT at 200 mM imidazole. Fractions containing VFT pure protein or
full-length PA0575 (see Supporting Information materials for details)
were pooled, imidazole was removed with PD-10 desalting columns
(GE Healthcare) and concentrated with 10 kDa cut-off Ultracel Ami-
con concentrators. The VFT sample was than loaded on a FPLC col-
umn (Superdex 75 16/600, GE Healthcare) and eluted with buffer A
using an FPLC apparatus (AKTA system). Full-length protein purity
was assessed to be 50%; activity assay was performed with freshly
purified fractions. Purified VFT protein was flash frozen in liquid nitro-
gen and stored at −20C. Protein content was evaluated with BCA
assay (Sigma-Aldrich) and for VFT also spectroscopically.
2.3 | Isothermal titration calorimetry (ITC) assays
Isothermal titration calorimetry (ITC) experiments were carried out
using an iTC200 microcalorimeter (MicroCal). Optimal conditions for
VFT titrations with different amino acids were: 1.2 μL aliquots of
amino acid solution (0.6 mM, pH 8.5, in the same buffer of protein
solution) injected into a 32 μM VFT solution (20 mM Tris-Hcl, pH 8.5,
150 mM NaCl); time interval between injections was 180 seconds.
ITC data were analyzed by integrating the heat exchange for each
addition and normalized for the amount of injected protein; the heat
exchange due to the dilution of the amino acid solution (0.2 mM) into
the ITC buffer was subtracted, as normalized value, to the titration
data. The heat of binding (H), the stoichiometry (n), and the dissocia-
tion constant (KD) were then calculated from plots of the heat evolved
per mole of ligand injected versus the molar ratio of ligand to protein
using the Origin software provided by the vendor (single binding site
equation). Data are the mean of at least three experiments SD.
2.4 | Kinetic assays
Possible PDE and/or DGC activities were evaluated by reverse-phase
high-performance liquid chromatography (RP-HPLC), as previously
described.36 Briefly, protein solution (2 μM) was incubated at 25C for
10 min in 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 2.5 mM MnCl2,
0,5% v/v Tween20 and then 100 μM GTP or 30 μM c-di-GMP was
added to evaluate DGC or PDE activity, respectively. About 150 μL of
reactions were stopped at selected times by adding 150 μL of 50 mM
EDTA pH 6.0 and boiled for 10 min. Reactions were centrifuged for
10 min at 13 000 rpm and the protein precipitate was removed with
0.2 μm filters (Bilk GHP Acrodisc 13 mm). The reactions products
were separated using a 150 x 4.6 mm reverse phase column (Prevail
C8, Grace Davison Discovery Science, particle size of 5 μm) with
100 mM phosphate buffer pH 5.8/ methanol (98/2, v/v, 1 mL min−1)
as mobile phase and set the UV detector at 252 nm.
2.5 | Bacterial strains, growth conditions and
chemicals
E. coli and P. aeruginosa strains used in this study are listed in Support-
ing Information Table S1. Bacterial cultures were grown at 37C in
Luria-Bertani broth,37 LB supplemented with 1.5% (w/v) agar, or M9
Minimal Medium37 supplemented with 20 mM L-arginine, L-lysine, L-
glutamic acid or L-leucine as carbon sources. When required, the fol-
lowing chemicals were added to the growth media: ampicillin (Ap,
100 μg mL−1), chloramphenicol (Cm, 30 μg mL−1), tetracycline (Tc,
10 μg mL−1), nalidixic acid (Nal, 15 μg mL−1), for E. coli; carbenicillin
(Cb, 300 μg mL−1), chloramphenicol (Cm, 375 μg mL−1), tetracycline
(Tc, 200 μg mL−1), sucrose 10% (w/v), for P. aeruginosa. Chemicals,
including synthetic pyocyanin, were purchased from Sigma–Aldrich.
2.6 | Construction of P. aeruginosa ΔPA0575 and
pPA0575 plasmid
The P. aeruginosa PAO1 ΔPA0575 chromosomal deletion mutant
was constructed by allelic exchange using the suicide vector
pDM4-PA0575 (Supporting Information Table S1) as previously
described38,39 pDM4-PA0575 was made as follows; using PAO1 tem-
plate DNA, upstream (UP) and downstream (DW) fragments of the
PA0575 genes were amplified with primer pairs FW-PA0575-UP (5'-
TATTCTAGAGCTTGGCGAGCGCATG-30) and RV-PA0575-UP (5'-
TATGAATTCCTGCATGAGGCGGTCTCG-30), or FW-PA0575-DW (5'-
TATGAATTCGAGCAGATCCAGGGCTTC-30) and RV-PA0575-DW (5'-
TATGTCGACGCCTGTTCAGGGTGACTGA-30), respectively.
The resulting PA0575-UP and PA0575-DW PCR products were
cloned in pBluescript-II KS+ with XbaI-EcoRI and EcoRI-SalI restriction
enzymes, respectively, resulting in the plasmids pBS-PA0575-UP and
pBS-PA0575-DW (Supporting Information Table S1). The PA0575-UP
and PA0575-DW fragments were then excised with the correspond-
ing restriction enzymes and both cloned in the suicide vector
pDM4,38 resulting in the pDM4-PA0575 plasmid. Allelic exchange in
P. aeruginosa PAO1 following conjugal mating with the E. coli S17.1
λpir pDM4-PA0575 donor strain and sucrose counter-selection was
performed as described by.39 Among sucrose-resistant clones, the
PAO1 ΔPA0575 mutant was selected by PCR and verified by
sequence analysis.
The complementation plasmid pPA0575 is based on the pUCP18
vector40 (Supporting Information Table S1). Briefly, the PA0575 gene
was amplified from PAO1 chromosomal DNA with primers FW-
PA0575 (5'-TATGGATCCGCCAGATCGAAGC-30) and RV-PA0575,
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and the resulting PCR product was cloned in pUCP18 via BamHI-XbaI
restriction.
2.7 | Phenotypic assays
Measurement of PcdrA::lux activity was performed as previously
described in.41,42 Briefly the mini-CTX-lux empty vector43 (Supporting
Information Table S1) and its derivative mini-CTX-PcdrA::lux41
(Supporting Information Table S1) were conjugated in PAO1 wild type
and ΔPA0575 strains by standard methods.37 The resulting strains,
containing or not pUCP18 or pPA0575, were grown for 16 h at 37C
with shaking in M9 supplemented with 20 mM L-arginine, L-lysine, L-
glutamic acid or L-leucine as carbon sources, and 300 μg mL−1 Cb for
strains containing pUCP18 or pPA0575 plasmids. These pre-cultures
were diluted to an A600 of 0.05 into M9 supplemented with 20 mM
of the same carbon source as in the pre-culture, and 200 μL of the
resulting bacterial suspensions were dispensed in black, flat-clear-
bottom 96-well microtiter plates. Microtiter plates were incubated at
37C with shaking at 120 rpm. Cell density (A600) and biolumines-
cence (relative light units, RLU) were simultaneously measured after
9 h incubation in a Spark 10 M multilabel plate reader (Tecan). PcdrA::
lux activity was calculated as RLU normalized to A600.
For biofilm formation assays, PAO1 wild type and ΔPA0575
strains containing or not the pUCP18 empty vector or the pPA0575
plasmids were grown for 16 h at 37C with shaking in M9 minimal
medium supplemented with 20 mM L-arginine, L-lysine, L-glutamic
acid or L-leucine as carbon sources, and 300 μg mL−1 Cb for strains
containing pUCP18 or pPA0575 plasmids. These precultures were
diluted to an A600 of 0.05 into M9 supplemented with 20 mM of the
same carbon source as in the preculture, and 200 μL of the resulting
bacterial suspensions were dispensed in polystyrene 96-well microti-
ter plates. Microtiter plates were incubated at 37C in static condition
for 16 h before measuring cell density (A600) and biofilm formation by
standard crystal violet staining (A595).
44 Biofilm adhesion units were
calculated as A595 normalized to A600.
Swarming and swimming motility assays were performed as previ-
ously described,45 in the presence or the absence of 20 mM
L-arginine.
3 | RESULTS AND DISCUSSION
3.1 | In silico analysis of the VFT domain of PA0575
To identify the most promising GGDEF/EAL candidates involved in
nutrient sensing, we looked for the presence of VFT-periplasmic
domains among the 38 genes from P. aeruginosa genome harboring
GGDEF and/or EAL domains.19 We found that the PA0575 gene con-
tains a VFT domain at the periplasmic N-terminal region (from residue
23, till residue 274), likely involved in signal recognition and transduc-
tion. To get insights into the structure-function relationships of this
domain and to identify the signal controlling PA0575 activity, we built a
homology model of the VFT domain, using the known crystal structures
of the two most similar homologous proteins, that is, an arginine-
binding protein (AncQR) from Escherichia coli (PDB: 4ZV1, arginine-
bound complex; sequence identity: 29%) and the periplasmic VFT2
domain of Bortedella pertussis (PDB: 3MPK; sequence identity: 28%)
(Figure 1 A and Supporting Information Figure S1 for energy graph).
The VFT domain of PA0575 presents the typical dual-lobe α/β
subdomain architecture shown by AncQR and VFT2, as expected for
this-fold (Figure 1 B). The two mobile sub-domains are connected by
a two-stranded β-sheet (residues 120-124 and 218-221), acting as a
hinge and allowing the opening/closure conformational transition
upon ligand binding.46
In the AncQR VFT domain, an L-arginine molecule is bound at the
interface between the two subdomains47: L-arginine binds Glu17, with
ion-pair and ion–dipole interactions between its guanidinium group
and the side-chain and main-chain of Glu17, respectively. Moreover,
the guanidinium group of the bound L-arginine is π-stacked between
the aromatic rings of Phe20 and Phe58. In PA0575, the corresponding
residues are represented by Asp44, Trp47, and Trp86. Residues inter-
acting with the α-amino and α-carboxylate moieties of L-arginine are
also well conserved (Arg83 and Asp167 in AncQR; Arg110 and
Asp192 in PA0575) (Figure 1 C). Similar binding geometries were
found also in other arginine-binding proteins (eg, PDB: 1LAF, 2Q2A,
and 2Y7I;47), supporting the hypothesis that PA0575 could also sense
the presence of L-arginine via its VFT domain.
It should be mentioned that another structure of a VFT domain
bound to L-arginine has been recently published, belonging to the
periplasmic portion of CdgH protein from V. cholera, which is con-
nected to a GGDEF domain responsible for the rugosity of this bacte-
rium.48 In spite of sharing the presence of coupled GGDEF and VFT
modules, a sequence comparison of the CdgH and PA0575 VFT
domains returned a very low sequence identity (≈13.6%), suggesting a
very remote homology. This is also evident by comparing the diverse
orientation and binding mode of L-arginine into the active site of the
two domains, and the identity of the active site residues involved in
L-arginine binding (Figure 1 D), which are instead almost identical to
AncQR from Escherichia coli (Figure 1 C).
Moreover, an analysis of the sequences homologous to PA0575
in PFAM49 highlighted the presence of the same domains architecture
of PA0575 only in the Pseudomonas genus, thus suggesting that in this
genus L-arginine sensing required the evolution of dedicated means to
fine tune intracellular metabolism.
3.2 | The N-terminal domain of PA0575 binds to L-
arginine
To validate the in silico predictions, the periplasmic portion of
PA0575 (residues 21-255 of VFT) was expressed and purified to
homogeneity; the domain is monomeric in solution, both in the pres-
ence and in the absence of 1 mM L-arginine in the buffer (Supporting
Information Figure S2A). Excess L-arginine increases the thermal sta-
bility of the protein (Supporting Information Figure S2B), thus sug-
gesting that an interaction between the VFT and this amino acid
occurs. To quantitatively determine the thermodynamics of the inter-
action, we performed a titration by Isothermal Titration Calorimetry
(ITC). ITC data clearly show that the VFT domain binds L-arginine with
a KD = 11.9 0.9 μM and a stoichiometry of 0.8 0.1 per monomer
(Figure 2 and Supporting Information Figure S3). The thermodynamic
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signature indicates that the binding is both entropy and enthalpy
driven, thus suggesting that hydrogen bonding and hydrophobic inter-
actions represent the driving force of the affinity (Figure 2, upper
panel, inset). The measured affinity is comparable to that of the struc-
tural template AncQR (KD_VFT = 11.9 vs KD_AncQR = 5.7 μM), but in
AncQR the binding is enthalpy driven, and the unfavorable entropic
factor indicates that a conformational rearrangement occurs upon
binding of L-arginine. The diversity of thermodynamic signatures,
including the considerable range of ΔH and TΔS, observed for similar
binding to homologous VFTs has been already acknowledged by pre-
vious studies.47 More in general, members of the polar amino acid-
binding protein (AABP) family may display different thermodynamic
profiles, though sharing conserved structural determinants for the rec-
ognition of amino acids.50
Interestingly, binding is highly specific for L-arginine, given that
no other amino acids such as lysine, leucine or glutamic acid were
FIGURE 1 Homology model of the periplasmic N-terminal Venus flytrap (VFT) domain of PA0575 and comparison with other L-arginine binding
VFT domains. (A) Sequence alignment of the VFT domain of PA0575 and the two structural templates used to build the homology model, that is,
AncQR (4ZV1 in the figure), an ancestral arginine-binding protein and the periplasmic VFT2 domain of Bortedella pertussis (3MPK in the figure).
(B) Cartoon representation of the entire domain. Polar interactions between L-arginine and the protein moiety are shown in yellow. The
corresponding positions of AncQR from Escherichia coli (PDB: 4ZV1) are represented as transparent pink sticks. (C) Structural superposition
between the VFT model of PA0575 (green sticks) and AncQR (pink sticks). Residues are labeled according to sequence numbering. Nitrogen and
oxygen atoms are colored blue and red, respectively. (D) Structural superposition between the VFT model of PA0575 (green sticks) and the
periplasmic portion of CdgH protein from V. Cholera (PDB: 5GZS; cyan sticks)
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able to bind to VFT (Figure 2). To further validate the structural
determinants of L-arginine binding, the two residues predicted to be
crucial, that is, Asp44 and Trp47, were mutated into Ala and Leu,
respectively. The double mutation completely abolishes the ability of
VFT to bind L-arginine (Figure 2), thus confirming the predicted bind-
ing mode, which is deeply different from that observed in the peri-
plasmic VFTs from the Vibrio cholerae CdgH protein.48 Nevertheless,
regardless of the different ligand-recognition mechanism, arginine
sensing, independent of its internalization could represent a
common, yet poorly explored trait of bacteria connected to the con-
trol of c-di-GMP levels.48,51
3.3 | PA0575 modulates c-di-GMP levels in
response to L-arginine
To probe the possible effect of L-arginine on PA0575 activity in vivo,
a P. aeruginosa PAO1 mutant strain deleted in the PA0575 gene was
generated by allelic exchange38 and the intracellular levels of c-di-
GMP produced by the wild type PAO1 and its isogenic ΔPA0575
mutant were compared by monitoring the activity of the c-di-GMP-
reporter cassette PcdrA::lux in these strains. Because the PcdrA pro-
moter is induced by high c-di-GMP levels, light emission in
P. aeruginosa strains carrying the PcdrA::lux cassette is proportional to
the intracellular concentration of c-di-GMP.41,42 Briefly, PAO1 wild
type and ΔPA0575 strains, both carrying the PcdrA::lux cassette, were
grown in M9 minimal medium supplemented (alternatively) with
20 mM arginine, lysine, glutamic acid, or leucine as sole carbon
sources, and NH4Cl as saturating nitrogen source. Light emission and
cell density were recorded in the resulting cultures after 9 h incuba-
tion at 37C. As shown in Figure 3A, PcdrA activity was >50% higher
in the ΔPA0575 strain relative to PA01 wild type when L-arginine was
used as carbon source, and this phenotype could be complemented by
constitutive expression of PA0575 via the pUCP18-derived plasmid
pPA0575. Conversely, no significant difference was observed in PcdrA
activity between the wild type and ΔPA0575 strains when M9 was
supplemented with lysine, glutamic acid, or leucine as sole carbon
sources (Figure 3 A). No difference in light emission from the same
strains containing the mini-CTX-lux empty vector was observed, irre-
spective of the amino acid used as carbon source, supporting the
specificity of PA0575 effect on the PcdrA promoter (Supporting Infor-
mation Figure S4A). These data strongly indicate that PA0575 acts as
a c-di-GMP PDE in PAO1, as previously shown for its homologous
protein RmcA in PA14,21 and that the ability of PA0575 to decrease
c-di-GMP levels in PAO1 is L-arginine dependent.
Previous results indicated that the secreted virulence factor pyo-
cyanin could be involved in the cytoplasmic regulation of RmcA activ-
ity in PA14.21 To investigate this issue in PAO1 and to identify
possible synergistic/competitive interactions between L-arginine and
pyocyanin in controlling PA0575 activity, PcdrA::lux activity was moni-
tored in PAO1 wild type and ΔPA0575 grown in M9 minimal medium
supplemented alternatively with 20 mM arginine or glutamic acid, in
the absence or in the presence of different concentrations of exoge-
nously added pyocyanin. Our data indicate that pyocyanin does not
affect PcdrA activity in the tested strains up to a concentration of
25 μM (ie, 4 folds higher than the maximal concentration of pyocya-
nin produced by PAO152), irrespective of the presence of arginine or
glutamic acid in the medium (data not shown).
A decrease in intracellular c-di-GMP levels often negatively
affects biofilm formation1 and other surface/motility behaviors;
hence, we compared the effect exerted by arginine and the other
amino acids on biofilm formation in wild type PAO1 and ΔPA0575.
When L-arginine was used as sole carbon source, biofilm adhesion
units were ~12% higher in PAO1 ΔPA0575 relative to PAO1 wild
type, while decreased of ~35% in PAO1 ΔPA0575-carrying plasmid
FIGURE 2 Binding of L-arginine to purified VFT. Binding of L-arginine
to VFT was assayed by isothermal titration calorimetry (ITC), by
titrating a VFT solution (32 μM) with different amounts of L-arginine
(600 μM in the ligand syringe) at 25C in 20 mM Tris pH 8.5, 150 mM
NaCl. The upper panel shows the heat exchange in time; in the lower
panel the normalized enthalpy exchange (black squares, reported as
kcal/Mol of injectant) has been reported as a function of the
molar ratio between the injectant and the macromolecule. Data
were fitted with the single binding site equation with the origin
software, as provided by the vendor (continuous line), yielding
the following parameters: N = 0.8  0.1; KD = 11.9  0.9 μM;
ΔH = −4.3  0.3 kcal mol−1; ΔS = 8.0  0.9 cal mol−1 deg−1; the
corresponding thermodynamic signature plot has been also reported
(upper panel, inset). Titration was repeated with the D44A/W47 L
double mutant of VFT, under the same experimental conditions
(empty diamonds, in the lower panel); the mutations do not alter the
overall secondary structure, as verified by CD spectrum (Supporting
Information igure S3C). To verify the specificity of binding, wild-type
VFT was titrated with other amino acids such as L-lysine, L-glutamic
acid and L-leucine (empty squares, circles and triangles, respectively),
under the same experimental conditions
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pPA0575 relative to the same strain carrying the empty vector
pUCP18 (Figure 3 B). The same trend is not observed when lysine,
glutamic acid, or leucine was used as carbon sources (Figure 3B).
Increased biofilm biomass in the PA0575 mutant was not due to
altered cell-density of the corresponding planktonic culture
(Supporting Information Figure S4B). These data are in accordance
with the hypothesis that PA0575 decreases c-di-GMP levels in
response to L-arginine.
The PA0575 mutation did not affect PAO1 swarming and swim-
ming motility, irrespective of the presence of L-arginine as carbon
source (Supporting Information Figure S4 panels C and D). It should
be mentioned that discrepancies on the role of RmcA on swarming
motility in PA14 were previously reported, with our data on this pleio-
tropic phenotype being consistent with results published by Okegbe
et al.,21 but not with data obtained by Ha et al.20
As also highlighted in a recent review2 it appears that the sensory
activity of PA0575/RmcA in PAO1 and PA14 is significantly affected
by the environmental conditions and that the phenotypes controlled
by this protein could be strain-dependent. Moreover, it is not possible
to exclude that the PA0575-dependent effector(s) could tune other
aspects of cell metabolism, which are known to be modulated by L-
arginine, than surface behaviour.11
Our in silico analysis proposes that PA0575 binds to L-arginine
and our in vivo data indicate that this protein responds to L-arginine
by lowering c-di-GMP levels (and consequently decreasing biofilm for-
mation) thus suggesting a PDE activity. Accordingly, we observed
PDE activity (but not a DGC) in vitro with the partially purified
PA0575 protein sample (Figure 3 C and Supporting Information
Figure S5), which is compatible with the aforementioned in vivo data
(ie, PA0575-dependent c-di-GMP decrease).
In agreement with other studies carried out on V. cholera,48, our
results underline that nutrient-dependent metabolism adaptation is
mediated, at least in part, by the second messenger c-di-GMP, whose
role is clearly wider than previously expected.
4 | CONCLUSIONS
L-arginine metabolism is emerging as a crucial factor in complex pro-
cesses involving metabolic-reprogramming, such as those related to
biofilm formation, immune response and cancer.26,27 L-arginine is at the
crossroads of complex metabolic networks that enable P. aeruginosa to
utilize this amino acid as a source of carbon, energy, and nitrogen. It
can be metabolized by several enzymes, such as arginine decarboxylase
(ADC), dehydrogenase (ADH), succinyl-transferase (AST, aerobic condi-
tions) and deiminase (ADI, which produces ATP under low oxygen ten-
sion and is inducible by exogenous L-arginine).53 Arginine fermentation
(ie, the ADI pathway) allows P. aeruginosa to survive under anaerobic
conditions when denitrification (ie, nitrates respiration) is not induced54
and is associated to chronic infections, biofilm/virulence,23,24 and anti-
biotic resistance.25 Interestingly, also the ADC pathway modulates the
host inflammatory response.55
Under aerobic conditions, the presence of L-arginine (even
together with ammonium) in the growth medium induces the maximal
expression of the Arginine-specific ABC transporters via the ArgR
transcription factor, mainly to sustain the AST pathway.53,56 It is
known that in the P. aeruginosa PA14 strain, L-arginine negatively
affects swarming motility, increases biofilm formation and, to a lower
extent, c-di-GMP levels as compared to glucose-supplemented
medium; moreover, metabolic fluxes involving arginine catabolism are
enhanced.57,58
Given the plethora of pathways dependent on L-arginine, it is not
surprising that P. aeruginosa has evolved a protein system such as the
multidomain protein PA0575 to directly connect this metabolite to
FIGURE 3 PA0575 decreases c-di-GMP levels. Effect of PA0575 gene deletion (ΔPA0575 in the figure) on c-di-GMP levels in PAO1. PcdrA::lux
activity (A) and biofilm adhesion units (B) measured in the indicated strains grown in M9 minimal medium supplemented with L-arginine (white
bars), L-lysine (light-gray bars), L-glutamic acid (dark-gray bars), or L-leucine (black bars) as sole carbon sources. Means of three independent
cultures are reported with SD. Indicated P-values were calculated by one-way ANOVA with Tukey's multiple comparison test. Data were compared
with the wild type strain and in the corresponding strain carrying the pUCP18 plasmid. The latter conditions represent the reference for the
complemented strain, ΔPA0575 pPA0575 in the figure. (C) Pilot enzymatic assays on partially purified full-length PA0575. The nucleotide content
of the reaction mixture, containing 2 μM of protein sample, excess GTP (100 μM; dashed line), or c-di-GMP (50 μM, continuous line), was
separated by HPLC (on a C8 RP column) to assess the DGC or the PDE activity, respectively. While the PDE reaction yields the expected product
(ie, pGpG), no c-di-GMP accumulates starting from GTP, under these experimental conditions
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the fine tuning of c-di-GMP and biofilm formation. Structural and
mechanistic details on PA0575 will contribute to depict the metabolic
events occurring in this bacterium in response to nutrients such as L-
arginine, to possibly target in the future the environment-mediated
metabolic reprogramming leading to biofilm formation.
ACKNOWLEDGMENTS
The authors acknowledge Ministero dell'Istruzione, dell'Università e
della Ricerca of Italy [RBFR10LHD1 to SR and GR], Sapienza
University of Rome [to FC RP11715C644A5CCE and SR
RM11715C646D693E] for financial support. The Grant of Excellence
Departments, MIUR-Italy (ARTICOLO 1, COMMI 314 - 337 LEGGE
232/2016) is also acknowledged.
ORCID
F Mantoni http://orcid.org/0000-0001-6828-882X
REFERENCES
1. Romling U, Galperin MY, Gomelsky M. Cyclic di-GMP: the first
25 years of a universal bacterial second messenger. Microbiol Mol Biol
Rev. 2013;77(1):1-52.
2. Ha DG, O'Toole GA. C-di-GMP and its effects on biofilm formation
and dispersion: a Pseudomonas aeruginosa review. Microbiol Spectrum.
2015;3(2):MB-0003-2014.
3. Levi A, Folcher M, Jenal U, Shuman HA. Cyclic diguanylate signaling
proteins control intracellular growth of Legionella pneumophila. MBio.
2011;2(1):e00316-e00310.
4. Lori C, Ozaki S, Steiner S, et al. Cyclic di-GMP acts as a cell cycle oscil-
lator to drive chromosome replication. Nature. 2015;523(7559):
236-239.
5. Dahlstrom KM, Collins AJ, Doing G, et al. A multimodal strategy used
by a large c-di-GMP network. J Bacteriol. 2018;200(8):E00703-E00717.
6. Petrova OE, Cherny KE, Sauer K. The diguanylate cyclase GcbA facili-
tates Pseudomonas aeruginosa biofilm dispersion by activating BdlA. J
Bacteriol. 2015;197(1):174-187.
7. Matsuyama BY, Krasteva PV, Baraquet C, Harwood CS,
Sondermann H, Navarro MVAS. Mechanistic insights into
c-di-GMP-dependent control of the biofilm regulator FleQ from Pseu-
domonas aeruginosa. Proc Natl Acad Sci USA. 2016;113(2):E209-E218.
8. Chen MW, Kotaka M, Vonrhein C, et al. Structural insights into the
regulatory mechanism of the response regulator RocR from Pseudomo-
nas aeruginosa in cyclic Di-GMP signaling. J Bacteriol. 2012;194(18):
4837-4846.
9. Navarro MV, Newell PD, Krasteva PV, et al. Structural basis for
c-di-GMP-mediated inside-out signaling controlling periplasmic prote-
olysis. PLoS Biol. 2011;9(2):e1000588.
10. Moreira RN, Dressaire C, Barahona S, et al. BolA is required for the
accurate regulation of c-di-GMP, a central player in biofilm formation.
MBio. 2017;8(5):00443-17.
11. Rinaldo S, Giardina G, Mantoni F, Paone A, Cutruzzola F. Beyond
nitrogen metabolism: nitric oxide, cyclic-di-GMP and bacterial bio-
films. FEMS Microbiol Lett. 2018;365:fny029.
12. Pu M, Sheng L, Song S, Gong T, Wood TK. Serine hydroxymethyltrans-
ferase ShrA (PA2444) controls rugose small-colony variant formation
in Pseudomonas aeruginosa. Frontiers in Microbiology. 2018;9:315.
13. Erez A, Kolodkin-Gal I. From prokaryotes to cancer: glutamine flux in
multicellular units. Trends Endocrinol Metab. 2017;28(9):637-644.
14. Felder CB, Graul RC, Lee AY, Merkle HP, Sadee W. The Venus flytrap
of periplasmic binding proteins: an ancient protein module present in
multiple drug receptors. AAPS PharmSci. 1999;1(2):E2.
15. Cortes-Hernandez P, Domínguez-Ramírez L. Role of cis-trans proline
isomerization in the function of pathogenic enterobacterial periplas-
mic binding proteins. PLoS One. 2017;12(11):e0188935.
16. Vanderstraete M, Gouignard N, Ahier A, Morel M, Vicogne J,
Dissous C. The venus kinase receptor (VKR) family: structure and evo-
lution. BMC Genom. 2013;14:361.
17. Conigrave AD, Mun HC, Lok HC. Aromatic L-amino acids activate the
calcium-sensing receptor. J Nutr. 2007;137(6 Suppl 1):1524S-1527S.
discussion 1548S.
18. Bauer WJ, Luthra A, Zhu G, Radolf JD, Malkowski MG, Caimano MJ.
Structural characterization and modeling of the Borrelia burgdorferi
hybrid histidine kinase Hk1 periplasmic sensor: a system for sensing
small molecules associated with tick feeding. J Struct Biol. 2015;
192(1):48-58.
19. Kulasakara H, Lee V, Brencic A, et al. Analysis of Pseudomonas aerugi-
nosa diguanylate cyclases and phosphodiesterases reveals a role for
bis-(30-50)-cyclic-GMP in virulence. Proc Natl Acad Sci USA. 2006;
103(8):2839-2844.
20. Ha DG, Richman ME, O'Toole GA. Deletion mutant library for investi-
gation of functional outputs of cyclic diguanylate metabolism in Pseu-
domonas aeruginosa PA14. Appl Environ Microbiol. 2014;80(11):
3384-3393.
21. Okegbe C, Fields BL, Cole SJ, et al. Electron-shuttling antibiotics struc-
ture bacterial communities by modulating cellular levels of c-di-GMP.
Proc Natl Acad Sci USA. 2017;114(26):E5236-E5245.
22. Taylor BL, Zhulin IB. PAS domains: internal sensors of oxygen, redox
potential, and light. Microbiol Mol Biol Rev. 1999;63(2):479-506.
23. Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT. In vivo evi-
dence of Pseudomonas aeruginosa nutrient acquisition and pathogene-
sis in the lungs of cystic fibrosis patients. Infect Immun. 2007;75(11):
5313-5324.
24. Schreiber K, Boes N, Eschbach M, et al. Anaerobic survival of Pseudo-
monas aeruginosa by pyruvate fermentation requires an Usp-type
stress protein. J Bacteriol. 2006;188(2):659-668.
25. Peng J, Cao J, Ng FM, Hill J. Pseudomonas aeruginosa develops cipro-
floxacin resistance from low to high level with distinctive proteome
changes. J Proteom. 2017;152:75-87.
26. Choi BS, Martinez-Falero IC, Corset C, et al. Differential impact of
L-arginine deprivation on the activation and effector functions of T
cells and macrophages. J Leukoc Biol. 2009;85(2):268-277.
27. Xiong L, Teng JL, Botelho MG, Lo RC, Lau SK, Woo PC. Arginine
metabolism in bacterial pathogenesis and cancer therapy. Int J Mol Sci.
2016;17(3):363.
28. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The
Phyre2 web portal for protein modeling, prediction and analysis. Nat
Protoc. 2015;10(6):845-858.
29. Janson G, Zhang C, Prado MG, Paiardini A. PyMod 2.0: improvements
in protein sequence-structure analysis and homology modeling within
PyMOL. Bioinformatics. 2017;33(3):444-446.
30. Bramucci E, Paiardini A, Bossa F, Pascarella S. PyMod: sequence simi-
larity searches, multiple sequence-structure alignments, and homology
modeling within PyMOL. BMC Bioinform. 2012;13(Suppl 4):S2.
31. Edgar RC. MUSCLE: a multiple sequence alignment method with
reduced time and space complexity. BMC Bioinform. 2004;5:113.
32. Rost B, Sander C. Combining evolutionary information and neural net-
works to predict protein secondary structure. Proteins. 1994;19(1):
55-72.
33. Paiardini A, Bossa F, Pascarella S. CAMPO, SCR_FIND and
CHC_FIND: a suite of web tools for computational structural biology.
Nucleic Acids Res. 2005;33(Web Server issue):W50-W55.
34. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. Evaluation of
comparative protein modeling by MODELLER. Proteins. 1995;23(3):
318-326.
35. Eisenberg D, Luthy R, Bowie JU. VERIFY3D: assessment of protein
models with three-dimensional profiles. Methods Enzymol. 1997;277:
396-404.
36. Stelitano V, Brandt A, Fernicola S, et al. Probing the activity of digua-
nylate cyclases and c-di-GMP phosphodiesterases in real-time by CD
spectroscopy. Nucleic Acids Res. 2013;41:e79.
37. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd
ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press,
Cold Spring Harbor Laboratory Press; 2001.
8 PAIARDINI ET AL.
38. Milton DL, O'Toole R, Horstedt P, Wolf-Watz H. Flagellin a is essential
for the virulence of Vibrio anguillarum. J Bacteriol. 1996;178(5):
1310-1319.
39. Westfall LW, Luna AM, San Francisco M, et al. The Pseudomonas aeru-
ginosa global regulator MvaT specifically binds to the ptxS upstream
region and enhances ptxS expression. Microbiology (Reading, England).
2004;150(Part 11):3797-3806.
40. Schweizer HP. Escherichia-pseudomonas shuttle vectors derived from
pUC18/19. Gene. 1991;97(1):109-121.
41. Pawar SV, Messina M, Rinaldo S, et al. Novel genetic tools to tackle
c-di-GMP-dependent signalling in Pseudomonas aeruginosa. J Appl
Microbiol. 2016;120(1):205-217.
42. Leoni L, Pawar SV, Rampioni G. Genetic tools to study
c-di-GMP-dependent signaling in Pseudomonas aeruginosa. Methods
Mol Biol. 2017;1657:471-480.
43. Becher A, Schweizer HP. Integration-proficient Pseudomonas aerugi-
nosa vectors for isolation of single-copy chromosomal lacZ and lux
gene fusions. Biotechniques. 2000;29(5):948-950. 952.
44. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary
for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;
30(2):295-304.
45. Rampioni G, Schuster M, Greenberg EP, Zennaro E, Leoni L. Contribu-
tion of the RsaL global regulator to Pseudomonas aeruginosa virulence
and biofilm formation. FEMS Microbiol Lett. 2009;301(2):210-217.
46. Lau AY, Roux B. The free energy landscapes governing conformational
changes in a glutamate receptor ligand-binding domain. Structure.
2007;15(10):1203-1214.
47. Clifton BE, Jackson CJ. Ancestral protein reconstruction yields insights
into adaptive evolution of binding specificity in solute-binding pro-
teins. Cell Chem Biol. 2016;23(2):236-245.
48. Xu M, Wang Y-Z, Yang X-A, Jiang T, Xie W. Structural studies of the
periplasmic portion of the diguanylate cyclase CdgH from vibrio cho-
lerae. Sci Rep. 2017;7:1861.
49. Finn RD, Bateman A, Clements J, et al. Pfam: the protein families data-
base. Nucleic Acids Res. 2014;42(Database issue):D222-D230.
50. Pulido NO, Silva DA, Tellez LA, et al. On the molecular basis of the
high affinity binding of basic amino acids to LAOBP, a periplasmic
binding protein from salmonella typhimurium. J Mol Recognit. 2015;
28(2):108-116.
51. Cockerell SR, Rutkovsky AC, Zayner JP, et al. Vibrio cholerae NspS, a
homologue of ABC-type periplasmic solute binding proteins, facilitates
transduction of polyamine signals independent of their transport.
Microbiology (Reading, England). 2014;160(Part 5):832-843.
52. Dietrich Lars EP, Price-Whelan A, Petersen A, Whiteley M,
Newman DK. The phenazine pyocyanin is a terminal signalling factor
in the quorum sensing network of Pseudomonas aeruginosa. Mol Micro-
biol. 2006;61(5):1308-1321.
53. Lu C-D, Yang Z, Li W. Transcriptome analysis of the ArgR regulon in
Pseudomonas aeruginosa. J Bacteriol. 2004;186(12):3855-3861.
54. Kuroki M, Igarashi Y, Ishii M, Arai H. Fine-tuned regulation of the
dissimilatory nitrite reductase gene by oxygen and nitric oxide in
Pseudomonas aeruginosa. Environ Microbiol Rep. 2014;6(6):
792-801.
55. Paulson NB, Gilbertsen AJ, Dalluge JJ, et al. The arginine decarboxyl-
ase pathways of host and pathogen interact to impact inflammatory
pathways in the lung. PLoS One. 2014;9(10):e111441.
56. Nishijyo T, Park S-M, Lu C-D, Itoh Y, Abdelal AT. Molecular characteri-
zation and regulation of an operon encoding a system for transport of
arginine and ornithine and the ArgR regulatory protein in Pseudomo-
nas aeruginosa. J Bacteriol. 1998;180(21):5559-5566.
57. Bernier SP, Ha DG, Khan W, Merritt JH, O'Toole GA. Modulation of
Pseudomonas aeruginosa surface-associated group behaviors by indi-
vidual amino acids through c-di-GMP signaling. Res Microbiol. 2011;
162(7):680-688.
58. Xu Z, Islam S, Wood TK, Huang Z. An integrated modeling and experi-
mental approach to study the influence of environmental nutrients on
biofilm formation of Pseudomonas aeruginosa. Biomed Res Int. 2015;
2015:12.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Sup-
porting Information section at the end of the article.
How to cite this article: Paiardini A, Mantoni F, Giardina G,
et al. A novel bacterial L-arginine sensor controlling c-di-GMP
levels in Pseudomonas aeruginosa. Proteins. 2018;1–9. https://
doi.org/10.1002/prot.25587
PAIARDINI ET AL. 9
